TickerFacts.

Biomerica Inc (BMRA): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2020-05-31, 2021-05-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$788.0K
Year ended 2026-05-31
-20.8%
3-year compound annual growth
-18.5%
5-year compound annual growth
$2.19M2011-05-31: $420.6K2012-05-31: $347.1K2013-05-31: $459.1K2014-05-31: $589.9K2015-05-31: $733.6K2016-05-31: $780.3K2017-05-31: $1.13M2018-05-31: $1.40M2019-05-31: $1.68M2020-05-31: $1.93M2021-05-31: $2.19M2022-05-31: $1.81M2023-05-31: $1.58M2024-05-31: $1.49M2025-05-31: $1.02M2026-05-31: $788.0K$788.0K
2011-05-31 R&D Expense (USD) 2026-05-31
Period endedR&D ExpenseChange YoYSource filing
2026-05-31$788.0K-23.0%2026-08-31, From 2025-06-01
2025-05-31$1.02M-31.4%2026-08-31, From 2024-06-01
2024-05-31$1.49M-5.9%2025-08-29, From 2023-06-01
2023-05-31$1.58M-12.6%2024-08-28, From 2022-06-01
2022-05-31$1.81M-17.4%2023-08-25, From 2021-06-01
2021-05-31$2.19Mn/c2022-08-29, From 2020-06-01
2020-05-31$1.93Mn/c2021-10-14, From 2019-06-01
2019-05-31$1.68M+20.1%2020-08-31, From 2018-06-01
2018-05-31$1.40M+23.7%2019-08-29, From 2017-06-01
2017-05-31$1.13M+44.9%2018-08-29, From 2016-06-01
2016-05-31$780.3K+6.4%2017-08-29, From 2015-06-01
2015-05-31$733.6K+24.4%2016-08-29, From 2014-06-01
2014-05-31$589.9K+28.5%2015-08-31, From 2013-06-01
2013-05-31$459.1K+32.3%2014-08-29, From 2012-06-01
2012-05-31$347.1K-17.5%2013-08-29, From 2011-06-01
2011-05-31$420.6Kn/a2012-08-29, From 2010-06-01

R&D Expense at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Biomerica Inc (BMRA)2026-05-31$788.0K-23.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$15.90M+61.6%
Anbio Biotechnology (NNNN)2025-12-31$201.3K-55.7%
Aspira Women's Health Inc. (AWHL)2025-12-31$2.88M-11.9%
Volitionrx Ltd (VNRX)2025-12-31$10.08M-30.0%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$245.07M+49.8%
Immucell Corp (ICCC)2025-12-31$3.04M-22.0%
Alpha Teknova, Inc. (TKNO)2025-12-31$2.20M-20.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$388.86M-16.6%

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗